Quick Answer
BIO-TECHNE Corp reported Diluted EPS of $0.46 per share for fiscal year 2025.
BIO-TECHNE Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.46 | -56.2% |
| 2024 | $1.05 | -40.3% |
| 2023 | $1.76 | +6.0% |
| 2022 | $1.66 | +90.8% |
| 2021 | $0.87 | -85.1% |
| 2020 | $5.82 | +135.6% |
| 2019 | $2.47 | -25.4% |
| 2018 | $3.31 | +63.1% |
| 2017 | $2.03 | -27.5% |
| 2016 | $2.80 | -3.1% |
| 2015 | $2.89 | -3.7% |
| 2014 | $3.00 | -1.6% |
| 2013 | $3.05 | +0.3% |
| 2012 | $3.04 | +0.7% |
| 2011 | $3.02 | +2.7% |
| 2010 | $2.94 | +5.8% |
| 2009 | $2.78 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.24 | +9.1% | +0.0% |
| September 30, 2025 | $0.24 | +14.3% | +71.4% |
| March 31, 2025 | $0.14 | -54.8% | -36.4% |
| December 31, 2024 | $0.22 | +29.4% | +4.8% |
| September 30, 2024 | $0.21 | -32.3% | -32.3% |
| March 31, 2024 | $0.31 | -27.9% | +82.4% |
| December 31, 2023 | $0.17 | -45.2% | -45.2% |
| September 30, 2023 | $0.31 | -43.6% | -27.9% |
- BIO-TECHNE Corp showed a decrease of -56.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, BIO-TECHNE Corp’s diluted eps has declined by 83.5% (from $2.78 per share to $0.46 per share).
- The most recent figure is from BIO-TECHNE Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: